Neonatal Abstinence Syndrome

"Neonatal Abstinence Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.

Descriptor ID	D009357
MeSH Number(s)	C16.614.610 C25.775.650 F03.900.650
Concept/Terms	Neonatal Abstinence Syndrome Neonatal Abstinence Syndrome Substance Withdrawal, Neonatal Neonatal Withdrawal Syndrome Neonatal Withdrawal Syndromes Syndrome, Neonatal Withdrawal Syndromes, Neonatal Withdrawal Withdrawal Syndrome, Neonatal Withdrawal Syndromes, Neonatal Abstinence Syndrome, Neonatal Abstinence Syndromes, Neonatal Neonatal Abstinence Syndromes Syndrome, Neonatal Abstinence Syndromes, Neonatal Abstinence Neonatal Substance Withdrawal Neonatal Substance Withdrawals Substance Withdrawals, Neonatal Withdrawal, Neonatal Substance Passive Addiction, Neonatal Passive Addiction, Neonatal Addiction, Neonatal Passive Addictions, Neonatal Passive Neonatal Passive Addiction Neonatal Passive Addictions Passive Addictions, Neonatal

Below are MeSH descriptors whose meaning is more general than "Neonatal Abstinence Syndrome".

Diseases [C]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Infant, Newborn, Diseases [C16.614]
Neonatal Abstinence Syndrome [C16.614.610]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Neonatal Abstinence Syndrome [C25.775.650]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Neonatal Abstinence Syndrome [F03.900.650]

Below are MeSH descriptors whose meaning is related to "Neonatal Abstinence Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Neonatal Abstinence Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neonatal Abstinence Syndrome" by people in this website by year, and whether "Neonatal Abstinence Syndrome" was a major or minor topic of these publications.

Bar chart showing 23 publications over 10 distinct years, with a maximum of 6 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	0	1
2013	1	0	1
2014	1	0	1
2016	1	0	1
2017	2	1	3
2018	2	1	3
2019	5	1	6
2020	2	0	2
2021	3	0	3
2022	2	0	2

Below are the most recent publications written about "Neonatal Abstinence Syndrome" by people in Profiles.

Diop H, Cui X, Nielsen T, Peacock-Chambers E, Gupta M. Length of Stay Among Infants with Neonatal Abstinence Syndrome and Risk of Hospital Readmission. Matern Child Health J. 2022 Oct; 26(10):2020-2029.

View in: PubMed
Sutter MB, Watson H, Yonke N, Weitzen S, Leeman L. Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study. BMC Pediatr. 2022 06 15; 22(1):345.

View in: PubMed
Borrelli KN, Yao EJ, Yen WW, Phadke RA, Ruan QT, Chen MM, Kelliher JC, Langan CR, Scotellaro JL, Babbs RK, Beierle JC, Logan RW, Johnson WE, Wachman EM, Cruz-Mart?n A, Bryant CD. Sex Differences in Behavioral and Brainstem Transcriptomic Neuroadaptations following Neonatal Opioid Exposure in Outbred Mice. eNeuro. 2021 Sep-Oct; 8(5).

View in: PubMed
Flanagan KE, Lal K, Blankenship K, Gorji N, Rork J, Wiss K. Nail disease in neonatal abstinence syndrome. Pediatr Dermatol. 2021 Jul; 38(4):787-793.

View in: PubMed
King RS, Peacock-Chambers E, Wilson D, Shimer J, Foss S, Visintainer P, Singh R. Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome. J Neonatal Perinatal Med. 2021; 14(4):463-473.

View in: PubMed
Peeler M, Gupta M, Melvin P, Bryant AS, Diop H, Iverson R, Callaghan K, Wachman EM, Singh R, Houghton M, Greenfield SF, Schiff DM. Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019). Am J Public Health. 2020 12; 110(12):1828-1836.

View in: PubMed
Peacock-Chambers E, Feinberg E, Senn-McNally M, Clark MC, Jurkowski B, Suchman NE, Byatt N, Friedmann PD. Engagement in Early Intervention Services Among Mothers in Recovery From Opioid Use Disorders. Pediatrics. 2020 02; 145(2).

View in: PubMed
Rodriguez N, Vining M, Bloch-Salisbury E. Salivary cortisol levels as a biomarker for severity of withdrawal in opioid-exposed newborns. Pediatr Res. 2020 05; 87(6):1033-1038.

View in: PubMed
Paterno MT, Jablonski L, Klepacki A, Friedmann PD. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes. J Obstet Gynecol Neonatal Nurs. 2019 Sep; 48(5):495-506.

View in: PubMed
Wachman EM, Hunter RG, Shrestha H, Lapp HE, Meyer J, Alvarez CD, Tronick E. Maternal hair cortisol levels as a novel predictor of neonatal abstinence syndrome severity: A pilot feasibility study. Dev Psychobiol. 2020 01; 62(1):116-122.

View in: PubMed

People

Explore

Similar Concepts

Top Journals